Cargando…
Immunotherapy and Pancreatic Cancer: A Lost Challenge?
Although immunotherapy has proved to be a very efficient therapeutic strategy for many types of tumors, the results for pancreatic cancer (PC) have been very poor. Indeed, chemotherapy remains the standard treatment for this tumor in the advanced stage. Clinical data showed that only a small portion...
Autores principales: | Laface, Carmelo, Memeo, Riccardo, Maselli, Felicia Maria, Santoro, Anna Natalizia, Iaia, Maria Laura, Ambrogio, Francesca, Laterza, Marigia, Cazzato, Gerardo, Guarini, Chiara, De Santis, Pierluigi, Perrone, Martina, Fedele, Palma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381818/ https://www.ncbi.nlm.nih.gov/pubmed/37511856 http://dx.doi.org/10.3390/life13071482 |
Ejemplares similares
-
The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies
por: Laface, Carmelo, et al.
Publicado: (2023) -
Immunotherapy and the Combination with Targeted Therapies for Advanced Hepatocellular Carcinoma
por: Laface, Carmelo, et al.
Publicado: (2023) -
Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives
por: Maselli, Felicia Maria, et al.
Publicado: (2023) -
The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions
por: Laface, Carmelo, et al.
Publicado: (2023) -
Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities
por: Laface, Carmelo, et al.
Publicado: (2022)